The National Medical Products Administration (NMPA), in conjunction with the China National Intellectual Property Administration (CNIPA), recently solicited public comments on the draft of “Measures For the Implementation of Early Resolution Mechanisms for Drug Patent Disputes (Trial)” ( Read More>>
Categories China, Government, Guest Contributors, International, IP News, IPWatchdog Articles, Legislation, Patents, China National Intellectual Property Administration, drug patents, generic drugs, Guest Contributor, intellectual property, legislation, National Medical Products Administration, patent, patent linkage
